Overview

A Phase 1, Open-Label Study of Teprotumumab in Patients With Diabetic Macular Edema (DME)

Status:
Completed
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
A Phase 1 Study to evaluate the Safety of teprotumumab in Patients with Diabetic Macular Edema.
Phase:
Phase 1
Details
Lead Sponsor:
River Vision Development Corporation